active pharmaceutical ingredients, cdsco, cipla, coronavirus, daiichi sankyo, fortis healthcare, fssai, glp-1 drugs, glp-1 weight loss drugs, health, ihh healthcare, india drug regulator, india pharma industry, journalist, journalists, minimum import price, news, obesity treatment, pharma, pharmaceutical industry, pharmaceutical industry in india, pharmaceutical supply chain, pharmexcil, semaglutide, sun pharma, ebola virus disease, schedule m compliance, pharma industry regulations, cervical cancer prevention, hpv vaccine india, middle east conflict, biocon